1.
Vemurafenib in patients with BRAFV600E -positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, ph...
by Brose, Marcia S, Dr
The lancet oncology, 2016, Vol.17 (9), p.1272-1282
Filter electronic articles 1 Hits
Remove Filters
- Mortality (1)
- Patients (1)
- Respiration (1)
- Thyroid (1)
- Squamous Cell Carcinoma (1)
- Skin (1)
- Metastasis (1)
- Metastases (1)
- Fda Approval (1)
- Dyspnea
- Drug Dosages (1)
- Hematology, Oncology And Palliat... (1)
- Iodine (1)
- Melanoma (1)
- Medical Prognosis (1)
- Lymphopenia (1)
- Cancer Therapies (1)
- less ...